<DOC>
	<DOCNO>NCT01531075</DOCNO>
	<brief_summary>The objective ass efficacy Hepatitis B Virus vaccination population IBD patient treat immunosuppressive medication .</brief_summary>
	<brief_title>Hepatitis B Vaccine Patients With Inflammatory Bowel Disease</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male/female â‰¥ 18 year age Evidence IBD diagnose clinical , laboratory image endoscopic criterion . Treated least one immunosuppressive medication time study initiation Provided write informed consent . Pregnant woman Diagnosis chronic viral hepatitis B Any major acute medical event 30 day prior recruitment necessitate hospitalization ( acute myocardial infarction , CVA , pulmonary embolus , sepsis , major trauma ) Any chronic inflammatory condition relate IBD ( connective tissue disease , Chronic liver disease , COPD , poorly control diabetes mellitus ) Active hematologic oncologic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>HBV , Inflammatory bowel disease , immunosuppressor</keyword>
</DOC>